Click here for printer-friendly version
* Operating revenue exceeded $15.0 billion with earnings of $835.2 million
* Selling, general and administrative expense ratio continued to improve, declining by 60 basis points from second quarter 2006
* Company repurchased 16.2 million shares of its common stock during the second quarter for $1.3 billion
* Full year 2007 earnings guidance raised to $5.55 per share
INDIANAPOLIS, July 25 /PRNewswire-FirstCall/ -- WellPoint, Inc.
(NYSE: WLP) today announced that second quarter 2007 net income was $835.2
million, or $1.35 per share, representing 15.4 percent growth over the second
quarter of 2006. Net income in the second quarter of 2006 was $751.2 million,
or $1.17 per share, including $0.01 per share in net realized investment
losses. The benefit expense ratio was 81.8 percent in the second quarter of
2007, an increase of 60 basis points compared to 81.2 percent in the second
quarter of 2006, and a 130 basis point improvement from 83.1 percent in the
first quarter of 2007.
"We continue to demonstrate our ability to consistently deliver strong
earnings growth while also providing members with new benefit options and
services that improve the affordability and quality of the health care they
receive," said Angela F. Braly, president and chief executive officer of
WellPoint, Inc. "As a result of our efforts during the first half of the
year, we are raising our full year earnings guidance to $5.55 per share and
continue to target long-term annual earnings per share growth of 15 percent.
At the same time, we continue to expand our efforts to find new solutions for
those who do not have health insurance in addition to undertaking strategic
initiatives to reduce growth in health care expenditures, increase
transparency, and promote improved quality."
"Our solid financial performance is reflective of our continued commitment
to improve operational efficiency and effectively deploy our capital," said
Wayne S. DeVeydt, chief financial officer of WellPoint, Inc. "In the first
six months of 2007, we generated operating cash flow of $2.7 billion, which
allowed us to repurchase 24.4 million shares of our common stock for $2.0
billion. As of June 30, 2007, our remaining Board-approved authorization was
$1.0 billion, which we intend to utilize during the remainder of the year. We
continue to expect full year 2007 operating cash flow of $4.4 billion."
CONSOLIDATED HIGHLIGHTS
Membership: Medical enrollment totaled 34.8 million members at June 30,
2007, an increase of 604,000 members from 34.2 million reported at June 30,
2006. The increase was driven by National Accounts and State Sponsored
business, which added 477,000 members and 364,000 members, respectively, over
the last twelve months. Growth from the prior year in State Sponsored
business excludes the impact of the change in the Company's 50 percent
ownership interest in a joint venture in Puerto Rico to a smaller percentage
ownership in the joint venture's parent company. Accordingly, the Company no
longer includes the 222,000 members related to this investment in its
enrollment. This growth was partially offset by declines in Individual and
Local Group business.
During the second quarter of 2007, medical enrollment declined by 108,000
members, led primarily by higher-than-expected in-group declines in National
Accounts, as the Company was impacted by employee reductions in various
industries, including the automobile, home building, mortgage, and related
sectors. The Company also experienced lower sequential claims volume in the
BlueCard program, which resulted in lower BlueCard membership as this
membership is estimated in part by the average BlueCard claims processed in
the period.
Sequentially, medical enrollment in Individual declined by 24,000 members
as rate increases were implemented in certain geographies. Local Group
enrollment was essentially flat as growth in the Company's Blue branded
business was offset by membership losses in the Company's non-Blue branded
businesses. State Sponsored enrollment increased by 31,000 members during the
quarter.
Operating Revenue: Operating revenue was $15.0 billion in the second
quarter of 2007, an increase of 7.5 percent from $14.0 billion in the prior
year second quarter. The increase resulted primarily from disciplined pricing
in Local Group business, growth in State Sponsored, Medicare Advantage, and
Medicare Part D membership, and increased reimbursement in the Federal
Employee Program ("FEP").
Benefit Expense Ratio: The benefit expense ratio was 81.8 percent in the
second quarter of 2007, a 130 basis point improvement from 83.1 percent in the
first quarter of 2007, driven primarily by a lower benefit expense ratio in
the Commercial and Consumer Business segment and the expected seasonality of
the Senior businesses. Additionally, the benefit expense ratio in State
Sponsored operations improved slightly due to the implementation of various
cost of care initiatives and expected seasonality.
The benefit expense ratio increased 60 basis points compared to 81.2
percent in the second quarter of 2006. The 60 basis point increase from the
prior year is primarily attributable to the Company's Specialty, Senior, and
State Sponsored Business segment.
Increases in State Sponsored claims experience in certain geographies
caused the benefit expense ratio to increase by 440 basis points in that line
of business between the second quarters of 2006 and 2007. Benefit expense
ratios were unacceptably high in California and Connecticut. The Company
continues to anticipate receiving rate increases in California effective
October 1, 2007 and in Connecticut retroactive to July 1, 2007. Additionally,
the Company has implemented numerous cost of care initiatives to improve
financial performance in these geographies. The Company remains disciplined
in its pricing and will take appropriate action if acceptable reimbursement
cannot be obtained.
The Life and Disability benefit expense ratio was also higher in the
second quarter of 2007 when compared to the second quarter of 2006, as the
prior year period was favorably impacted by a change in experience factors for
waiver of premium reserves that did not recur in 2007.
As expected, these increases were partially offset by a year-over-year
improvement in the benefit expense ratio for the Company's Commercial and
Consumer Business segment, reflecting disciplined underwriting and the timing
of prior period development in 2006.
Premium and Cost Trends: Trends include Local Group and Individual fully-
insured businesses.
For the rolling 12-month period ended June 30, 2007, the primary drivers
of medical trend were outpatient and inpatient costs. The Company continues
to price its commercial business so that expected premium yield exceeds total
cost trend, where total cost trend includes medical costs and selling, general
and administrative ("SG&A") expense.
Based on medical trends in the first and second quarters of 2007, the
Company continues to believe its 2007 medical cost trend estimate of less than
8.0 percent is appropriate.
SG&A Expense Ratio: The SG&A expense ratio was 15.1 percent in the second
quarter of 2007, a decrease of 60 basis points from 15.7 percent in the second
quarter of 2006. The ratio improved year-over-year as the Company continued
to control spending and spread administrative expenses across a growing
revenue base.
The SG&A expense ratio increased 70 basis points from the first quarter of
2007 as the Company resumed the discretionary spending that had been postponed
in the first quarter.
Operating Cash Flow: For the six months ended June 30, 2007, operating
cash flow totaled $2.7 billion, or 1.7 times net income. As expected, the
second quarter operating cash flow of $725.9 million was lower than the first
quarter as the Company made two federal income tax payments during the period
totaling $802.1 million and received one additional CMS payment in the first
quarter of 2007.
Days in Claims Payable: Days in claims payable as of June 30, 2007, was
45.5 days, an increase of 0.8 days from 44.7 days as of March 31, 2007. The
increase was primarily due to lower benefit expense per day, the timing of
medical claim payments, and increased provider incentive accruals, which were
partially offset by the timing of claim payments in the pharmacy benefit
management ("PBM") operation.
Share Repurchase Program: During the second quarter of 2007, the Company
repurchased 16.2 million shares of its common stock for $1.3 billion. As of
June 30, 2007, the Company's remaining Board-approved share repurchase
authorization was $1.0 billion. The Company intends to utilize the remaining
authorization during 2007, subject to market conditions. At June 30, 2007,
cash and investments held at the parent company and available for general
corporate use totaled $2.7 billion.
REPORTABLE SEGMENTS
WellPoint, Inc. has the following reportable segments: Commercial and
Consumer Business ("CCB"), Specialty, Senior, and State Sponsored Business
("4SB"), and Other, which includes FEP business, National Government Services,
Inc., intersegment sales and expense eliminations, and corporate expenses not
allocated to the other reportable segments.
Operating revenue and operating gain are the key measures used by
management to evaluate performance in each segment.
WellPoint, Inc.
Reportable Segment Highlights
(Unaudited)
(In millions) Three Months Ended June 30
2007 2006 Change
Operating Revenue
CCB $10,516.0 $10,148.4 3.6%
4SB 3,405.8 2,843.4 19.8%
Other:
External Customers 1,506.8 1,319.1 14.2%
Intersegment Eliminations (423.1) (349.4) (21.1%)
Other 1,083.7 969.7 11.8%
Total Operating Revenue 15,005.5 13,961.5 7.5%
Operating Gain (Loss)
CCB $1,013.9 $906.3 11.9%
4SB 212.8 287.0 (25.9%)
Other 7.3 (21.2) -
Operating Margin
CCB 9.6% 8.9% 70 bp
4SB 6.2% 10.1% (390) bp
`
WellPoint, Inc.
Reportable Segment Highlights
(Unaudited)
(In millions) Six Months Ended June 30
2007 2006 Change
Operating Revenue
CCB $20,933.8 $20,065.8 4.3%
4SB 6,740.2 5,625.0 19.8%
Other:
External Customers 2,974.8 2,586.8 15.0%
Intersegment Eliminations (810.9) (682.6) (18.8%)
Other 2,163.9 1,904.2 13.6%
Total Operating Revenue 29,837.9 27,595.0 8.1%
Operating Gain (Loss)
CCB $2,027.7 $1,888.4 7.4%
4SB 356.0 453.0 (21.4%)
Other 23.6 (33.8) -
Operating Margin
CCB 9.7% 9.4% 30 bp
4SB 5.3% 8.1% (280) bp
Commercial and Consumer Business: Operating gain for the CCB segment was
$1,013.9 million in the second quarter of 2007, an increase of 11.9 percent
compared to $906.3 million in the second quarter of 2006. Improved
performance in the CCB segment resulted from disciplined pricing and the
timing of prior period development in 2006.
Specialty, Senior, and State Sponsored Business: Operating gain for the
4SB segment totaled $212.8 million in the second quarter of 2007, a decrease
of 25.9 percent compared to $287.0 million in the second quarter of 2006. The
decrease from prior year is primarily attributable to higher medical claims
experience in certain State Sponsored geographies in 2007 and the favorable
impact of a change in experience factors for Life and Disability waiver of
premium reserves recorded in the second quarter of 2006 that did not recur in
2007.
Other: Operating gain for the Other segment totaled $7.3 million in the
second quarter of 2007, an improvement from the operating loss of $21.2
million in the second quarter of 2006. The improvement resulted primarily
from lower corporate expenses.
OUTLOOK
Full Year 2007:
-- The Company now expects net income of $5.55 per share, representing
growth of 15% over 2006.
-- Year-end medical enrollment is now expected to be approximately 35.1
million members, representing growth for the year of 1.0 million
members, or 3.0 percent.
-- Operating revenue is now expected to total approximately $60.5 billion.
-- The benefit expense ratio is expected to be approximately 81.9 percent.
-- The SG&A expense ratio is now expected to be approximately 14.8
percent.
-- The Company expects operating cash flow of $4.4 billion, or 1.3 times
net income.
Third Quarter 2007:
-- The Company continues to expect net income of $1.44 per share.
Basis of Presentation
1. Operating gain is defined as operating revenue less benefit expense,
selling expense, general and administrative expense, and cost of drugs.
Operating gain is used to analyze profit or loss on a segment basis.
Consolidated operating gain is a non-GAAP measure.
2. Operating margin is defined as operating gain divided by operating
revenue.
3. Certain prior period amounts have been reclassified to conform to
current period presentation.
Conference Call and Webcast
Management will host a conference call and webcast today at 8:30 a.m.
Eastern Daylight Time ("EDT") to discuss its second quarter earnings results.
The conference call should be accessed at least 15 minutes prior to the start
of the call with the following numbers:
888-423-3268 (Domestic) 800-475-6701 (Domestic Replay)
651-291-5254 (International) 320-365-3844 (International Replay)An access code is not required for today's conference call. The access
code for the replay is 857270. The replay will be available from 1:45 p.m.
EDT today until the end of the day on August 8, 2007. The call will also be
available through a live webcast at www.wellpoint.com under "Investor Info."
A webcast replay will be available following the call.
About WellPoint, Inc.
WellPoint's mission is to improve the lives of the people it serves and
the health of its communities. WellPoint, Inc. is the largest health benefits
company in terms of commercial membership in the United States. Through its
nationwide networks, the company delivers a number of leading health benefit
solutions through a broad portfolio of integrated health care plans and
related services, along with a wide range of specialty products such as life
and disability insurance benefits, pharmacy benefit management, dental,
vision, behavioral health benefit services, as well as long term care
insurance and flexible spending accounts. Headquartered in Indianapolis,
Indiana, WellPoint is an independent licensee of the Blue Cross and Blue
Shield Association and serves its members as the Blue Cross licensee for
California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut,
Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the
Kansas City area), Nevada, New Hampshire, New York (as Blue Cross Blue Shield
in 10 New York City metropolitan and surrounding counties and as Blue Cross or
Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia
(excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and
through UniCare. Additional information about WellPoint is available at
www.wellpoint.com.
WellPoint, Inc.
Medical Membership & Specialty Metrics Summary
(Unaudited and in Thousands)
Change from
June 30, June 30, Dec. 31, June 30, Dec. 31
Medical Membership 2007 2006 2006 2006 2006
Customer Type
Local Group (1) 16,688 16,701 16,766 (0.1%) (0.5%)
Individual 2,450 2,508 2,488 (2.3%) (1.5%)
National Accounts (1) 6,413 6,217 6,136 3.2% 4.5%
BlueCard 4,475 4,194 4,279 6.7% 4.6%
Total National 10,888 10,411 10,415 4.6% 4.5%
Senior 1,238 1,209 1,193 2.4% 3.8%
State Sponsored (2) 2,122 1,980 1,882 7.2% 12.8%
FEP 1,381 1,354 1,357 2.0% 1.8%
Total 34,767 34,163 34,101 1.8% 2.0%
Funding Arrangement
Self-Funded 17,425 16,980 16,745 2.6% 4.1%
Fully-Insured 17,342 17,183 17,356 0.9% (0.1%)
Total 34,767 34,163 34,101 1.8% 2.0%
Reportable Segment
Commercial & Consumer Business 30,026 29,620 29,669 1.4% 1.2%
Senior & State Sponsored 3,360 3,189 3,075 5.4% 9.3%
Other 1,381 1,354 1,357 2.0% 1.8%
Total 34,767 34,163 34,101 1.8% 2.0%
Specialty Metrics
PBM Prescription Volume (3) 98,054 96,919 95,685 1.2% 2.5%
Behavioral Health Membership 20,038 15,938 16,937 25.7% 18.3%
Life and Disability Membership 5,754 5,964 5,970 (3.5%) (3.6%)
Dental Membership 5,169 5,258 5,270 (1.7%) (1.9%)
Vision Membership 2,480 940 1,536 163.8% 61.5%
Medicare Part D Membership (4) 1,594 1,527 1,568 4.4% 1.7%
(1) Effective January 1, 2007, WellPoint revised its definition of a
National Account to include multi-state employers primarily
headquartered in a WellPoint service area with 1,000 or more eligible
employees, of which at least 5% or more are located in a service area
outside of the headquarter's state.
(2) During the fourth quarter of 2006, the Company's ownership of a joint
venture in Puerto Rico changed from a 50 percent ownership of a
Medicaid managed care subsidiary to a smaller percentage ownership in
the joint venture's parent company. Accordingly, for December 31, 2006
and subsequent periods, the Company no longer includes the 222,000
members related to this investment in its reported enrollment.
(3) Represents quarterly prescription volume at the Company's PBM
operation.
(4) Includes auto-assigned, stand-alone, Medicare Advantage, group waiver
and external PBM members with the prescription drug plan benefit.
WellPoint, Inc.
Consolidated Statements of Income
(Unaudited)
Three Months Ended
(In millions, except per share data) June 30
2007 2006 Change
Revenues
Premiums $13,935.9 $12,918.8 7.9%
Administrative fees 923.6 896.3 3.0%
Other revenue 146.0 146.4 (0.3%)
Total operating revenue 15,005.5 13,961.5 7.5%
Net investment income 253.4 218.5 16.0%
Net realized gains (losses) on
investments 0.9 (8.9) -
Total revenues 15,259.8 14,171.1 7.7%
Expenses
Benefit expense 11,405.1 10,486.8 8.8%
Selling, general and administrative
expense
Selling expense 429.6 413.2 4.0%
General and administrative
expense 1,830.7 1,778.9 2.9%
Total selling, general and
administrative expense 2,260.3 2,192.1 3.1%
Cost of drugs 106.1 110.5 (4.0%)
Interest expense 100.1 103.9 (3.7%)
Amortization of other intangible
assets 70.9 74.5 (4.8%)
Total expenses 13,942.5 12,967.8 7.5%
Income before income taxes 1,317.3 1,203.3 9.5%
Income taxes 482.1 452.1 6.6%
Net income $835.2 $751.2 11.2%
Net income per diluted share $1.35 $1.17 15.4%
Diluted shares 617.9 642.0 (3.8%)
Benefit expense as a percentage of
premiums 81.8% 81.2% 60 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 15.1% 15.7% (60) bp
Income before income taxes as a
percentage of total revenues 8.6% 8.5% 10 bp
WellPoint, Inc.
Consolidated Statements of Income
(Unaudited)
Six Months Ended
(In millions, except per share data) June 30
2007 2006 Change
Revenues
Premiums $27,693.3 $25,497.7 8.6%
Administrative fees 1,848.4 1,799.1 2.7%
Other revenue 296.2 298.2 (0.7%)
Total operating revenue 29,837.9 27,595.0 8.1%
Net investment income 500.0 430.6 16.1%
Net realized gains (losses) on
investments 1.1 (16.0) -
Total revenues 30,339.0 28,009.6 8.3%
Expenses
Benefit expense 22,834.6 20,711.8 10.2%
Selling, general and administrative
expense
Selling expense 852.6 814.6 4.7%
General and administrative
expense 3,539.3 3,550.1 (0.3%)
Total selling, general and
administrative expense 4,391.9 4,364.7 0.6%
Cost of drugs 204.1 210.9 (3.2%)
Interest expense 203.0 197.9 2.6%
Amortization of other intangible
assets 141.7 148.3 (4.5%)
Total expenses 27,775.3 25,633.6 8.4%
Income before income taxes 2,563.7 2,376.0 7.9%
Income taxes 945.4 893.0 5.9%
Net income $1,618.3 $1,483.0 9.1%
Net income per diluted share $2.61 $2.26 15.5%
Diluted shares 620.5 655.5 (5.3%)
Benefit expense as a percentage of
premiums 82.5% 81.2% 130 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 14.7% 15.8% (110) bp
Income before income taxes as a
percentage of total revenues 8.5% 8.5% 0 bp
WellPoint, Inc.
Consolidated Balance Sheets
June 30, December 31,
(In millions) 2007 2006
(Unaudited)
Assets
Current assets:
Cash and cash equivalents $4,205.1 $2,602.1
Investments available-for-sale, at
fair value 3,773.8 2,449.9
Other invested assets, current 63.0 72.8
Accrued investment income 165.4 157.2
Premium and self-funded
receivables 2,626.8 2,335.3
Other receivables 1,261.2 1,172.7
Income taxes receivable 129.1 -
Securities lending collateral 985.2 904.7
Deferred tax assets, net 627.1 642.6
Other current assets 1,315.1 1,284.5
Total current assets 15,151.8 11,621.8
Long-term investments available-for-
sale, at fair value 14,976.8 15,687.4
Property and equipment, net 968.7 988.6
Goodwill 13,337.8 13,383.5
Other intangible assets 9,254.5 9,396.2
Other noncurrent assets 504.5 497.4
Total assets $54,194.1 $51,574.9
Liabilities and shareholders' equity
Liabilities
Current liabilities:
Policy liabilities:
Medical claims payable $5,702.9 $5,290.3
Reserves for future policy
benefits 76.4 76.3
Other policyholder liabilities 2,117.7 2,055.7
Total policy liabilities 7,897.0 7,422.3
Unearned income 1,665.7 987.9
Accounts payable and accrued
expenses 2,769.6 3,242.2
Income taxes payable - 538.2
Security trades pending payable 249.5 124.8
Securities lending payable 985.2 904.7
Current portion of long-term debt 520.0 521.0
Other current liabilities 1,682.5 1,397.4
Total current liabilities 15,769.5 15,138.5
Long-term debt, less current portion 7,652.2 6,493.2
Reserves for future policy benefits,
noncurrent 655.0 646.9
Deferred tax liability, net 2,897.1 3,350.2
Other noncurrent liabilities 2,231.5 1,370.3
Total liabilities 29,205.3 26,999.1
Shareholders' equity
Common stock 6.0 6.1
Additional paid-in capital 19,853.0 19,863.5
Retained earnings 5,122.1 4,656.1
Accumulated other comprehensive
income (loss) 7.7 50.1
Total shareholders' equity 24,988.8 24,575.8
Total liabilities and shareholders'
equity $54,194.1 $51,574.9
WellPoint, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
Six Months Ended June 30
(In millions) 2007 2006
Operating activities
Net income $1,618.3 $1,483.0
Adjustments to reconcile net income
to net cash provided by operating
activities:
Net realized (gains) losses on
investments (1.1) 16.0
Loss on disposal of assets 1.1 0.9
Deferred income taxes (228.1) (40.5)
Amortization, net of accretion 232.5 230.1
Depreciation expense 63.0 68.5
Share-based compensation 102.1 141.1
Excess tax benefits from
share-based compensation (127.1) (62.4)
Changes in operating assets and
liabilities, net of
effect of business
combinations:
Receivables, net (198.9) (467.6)
Other invested
assets, current 10.0 (95.2)
Other assets (39.1) (142.3)
Policy liabilities 484.8 468.8
Unearned income 677.8 539.4
Accounts payable and
accrued expenses (319.9) (304.0)
Other liabilities 201.9 181.2
Income taxes 254.9 (18.4)
Other, net (25.2) -
Net cash provided by operating
activities 2,707.0 1,998.6
Investing activities
Purchases of fixed maturity
securities (5,396.2) (8,141.8)
Proceeds from sales and maturities of
fixed maturity securities 4,273.3 7,955.4
Purchase of equity securities (817.1) (1,376.1)
Proceeds from sales of equity
securities 1,232.0 1,300.1
Changes in securities lending
collateral (80.5) 686.2
Purchases of property and equipment (120.1) (77.4)
Proceeds from sales of property and
equipment 7.6 4.6
Other, net (21.6) (24.7)
Net cash used in investing activities (922.6) 326.3
Financing activities
Net (repayments of) proceeds from
commercial paper borrowings (296.7) 191.5
Proceeds from long-term borrowings 1,478.3 2,668.9
Repayment of long-term borrowings (5.4) (2,156.7)
Changes in securities lending payable 80.5 (686.2)
Changes in bank overdrafts (145.9) 124.0
Repurchase and retirement of common
stock (1,957.7) (3,600.4)
Proceeds from exercise of employee
stock options and employee stock
purchase plan 538.4 265.8
Excess tax benefits from share-based
compensation 127.1 62.4
Net cash used in financing activities (181.4) (3,130.7)
Change in cash and cash equivalents 1,603.0 (805.8)
Cash and cash equivalents at
beginning of period 2,602.1 2,740.2
Cash and cash equivalents at end of
period $4,205.1 $1,934.4
WellPoint, Inc.
Reconciliation of Medical Claims Payable
Six Months Ended June 30
(In millions) 2007 2006
(Unaudited)
Gross medical claims payable,
beginning of period $5,290.3 $4,853.4
Ceded medical claims payable,
beginning of period (51.0) (27.7)
Net medical claims payable, beginning
of period 5,239.3 4,825.7
Business combinations and purchase
adjustments (2.0) (6.4)
Net incurred medical claims:
Current year 23,208.3 21,156.8
Prior years (redundancies) (1) (356.1) (556.7)
Total net incurred medical claims 22,852.2 20,600.1
Net payments attributable to:
Current year medical claims 17,973.0 16,534.4
Prior years medical claims 4,467.6 3,752.1
Total net payments 22,440.6 20,286.5
Net medical claims payable, end of
period 5,648.9 5,132.9
Ceded medical claims, end of period 54.0 29.7
Gross medical claims payable, end of
period $5,702.9 $5,162.6
Current year medical claims paid as a
percent of current year net incurred
medical claims 77.4% 78.2%
Prior year redundancies in the
current period as a percent of prior
year net medical claims payables less
prior year redundancies in the
current period 7.3% 13.0%
Prior year redundancies in the
current period as a percent of prior
year net incurred medical claims -
as reported (3) 0.8% 1.7%
Prior year redundancies in the
current period as a percent of prior
year net incurred medical claims -
adjusted for acquisitions (3) 0.8% 1.5%
(1) Negative amounts reported for net incurred medical claims related to
prior years result from claims being settled for amounts less than
originally estimated.
(2) This ratio is impacted by having only one month of net incurred
medical claims and payments for the former WellPoint Health Networks
Inc. ("WHN") in 2004. If WHN had not been included in 2004, current
year medical claims payments would have been $12,057.7 million,
current year net incurred medical claims would have been $13,835.1
million and the adjusted ratio would have been 87.2%.
(3) For all periods presented, except for the year ended December 31, 2004
and the six months ended June 30, 2007, the reported ratio of prior
year redundancies in the current period to prior year net incurred
medical claims is impacted by certain acquisitions (the former
WellChoice, Inc. in 2005 and WHN in 2004). The Company has provided
ratios adjusted for these acquisitions in order to these impacts.
Refer to the table entitled, "Reconciliation of Medical Claims Payable
- Adjusted Ratios" for details regarding the respective calculation
methodologies.
WellPoint, Inc.
Reconciliation of Medical Claims Payable
Year Ended December 31
(In millions) 2006 2005 2004
Gross medical claims payable,
beginning of period $4,853.4 $4,134.0 $1,836.0
Ceded medical claims payable,
beginning of period (27.7) (31.9) (8.7)
Net medical claims payable,
beginning of period 4,825.7 4,102.1 1,827.3
Business combinations and purchase
adjustments (6.4) 784.5 2,331.0
Net incurred medical claims:
Current year 42,613.2 32,865.6 15,344.9
Prior years (redundancies) (1) (617.7) (644.9) (171.9)
Total net incurred medical claims 41,995.5 32,220.7 15,173.0
Net payments attributable to:
Current year medical claims 37,486.0 28,997.1 12,453.2
Prior years medical claims 4,089.5 3,284.5 2,776.0
Total net payments 41,575.5 32,281.6 15,229.2
Net medical claims payable, end of
period 5,239.3 4,825.7 4,102.1
Ceded medical claims, end of period 51.0 27.7 31.9
Gross medical claims payable, end of
period $5,290.3 $4,853.4 $4,134.0
Current year medical claims paid as
a percent of current year net
incurred medical claims 88.0% 88.2% 81.2%(2)
Prior year redundancies in the
current period as a percent of
prior year net medical claims
payables less prior year
redundancies in the current period 14.7% 18.7% 10.4%
Prior year redundancies in the
current period as a percent of
prior year net incurred medical
claims - as reported (3) 1.9% 4.2% 1.4%
Prior year redundancies in the
current period as a percent of
prior year net incurred medical
claims - adjusted for acquisitions (3) 1.6% 2.1% 1.4%
(1) Negative amounts reported for net incurred medical claims related to
prior years result from claims being settled for amounts less than
originally estimated.
(2) This ratio is impacted by having only one month of net incurred
medical claims and payments for the former WellPoint Health Networks
Inc. ("WHN") in 2004. If WHN had not been included in 2004, current
year medical claims payments would have been $12,057.7 million,
current year net incurred medical claims would have been $13,835.1
million and the adjusted ratio would have been 87.2%.
(3) For all periods presented, except for the year ended December 31, 2004
and the six months ended June 30, 2007, the reported ratio of prior
year redundancies in the current period to prior year net incurred
medical claims is impacted by certain acquisitions (the former
WellChoice, Inc. in 2005 and WHN in 2004). The Company has provided
ratios adjusted for these acquisitions in order to these impacts.
Refer to the table entitled, "Reconciliation of Medical Claims Payable
- Adjusted Ratios" for details regarding the respective calculation
methodologies.
WellPoint, Inc.
Reconciliation of Medical Claims Payable - Adjusted Ratios
(Unaudited)
Note: Below are reconciliations for the adjusted ratios of prior year
redundancies in the current period to prior year net incurred medical
claims that are included in table entitled, "Reconciliation of Medical
Claims Payable."
Ratio for the Six Months Ended June 30, 2006
This ratio is impacted by having no net incurred
medical claims for the former WellChoice, Inc.
("WC") in 2005.
Net incurred medical claims related to prior years
(redundancies) - six months ended June 30, 2006
(As Reported) $556.7
Net incurred medical claims - year ended
December 31, 2005 (As Reported) $32,865.6
Ratio (As Reported) 1.7%
Net incurred medical claims - year ended
December 31, 2005 (Comparable Basis) 1 $37,676.0
Ratio (As Adjusted) 1.5%
1 Represents comparable benefit expense,
assuming WC had been owned for the
entire year ended December 31, 2005.
Ratio for the Year Ended December 31, 2006
This ratio is impacted by having no net incurred
medical claims for the former WellChoice, Inc.
("WC") in 2005.
Net incurred medical claims related to
prior years (redundancies) - year ended
December 31, 2006 (As Reported) $617.7
Net incurred medical claims - year ended
December 31, 2005 (As Reported) $32,865.6
Ratio (As Reported) 1.9%
Net incurred medical claims - year ended
December 31, 2005 (Comparable Basis) 1 $37,676.0
Ratio (As Adjusted) 1.6%
1 Represents comparable benefit expense,
assuming WC had been owned for the
entire year ended December 31, 2005.
Ratio for the Year Ended December 31, 2005
This ratio is impacted by having only one month of
net incurred medical claims for the former WellPoint
Health Networks Inc. ("WHN") in 2004.
Net incurred medical claims related to
prior years (redundancies) - year ended
December 31, 2005 (As Reported) $644.9
Net incurred medical claims - year ended
December 31, 2004 (As Reported) $15,344.9
Ratio (As Reported) 4.2%
Net incurred medical claims - year ended
December 31, 2004 (Comparable Basis) 2 $30,819.1
Ratio (As Adjusted) 2.1%
2 Represents comparable benefit expense,
assuming WHN had been owned for
the entire year ended December 31, 2004.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT
OF 1995
This document contains certain forward-looking information about
WellPoint, Inc. ("WellPoint") that is intended to be covered by the safe
harbor for "forward-looking statements" provided by the Private Securities
Litigation Reform Act of 1995. Forward-looking statements are statements that
are not generally historical facts. Words such as "expect(s)", "feel(s)",
"believe(s)", "will", "may", "anticipate(s)", "intend", "estimate", "project"
and similar expressions are intended to identify forward-looking statements.
These statements include, but are not limited to, financial projections and
estimates and their underlying assumptions; statements regarding plans,
objectives and expectations with respect to future operations, products and
services; and statements regarding future performance. Such statements are
subject to certain risks and uncertainties, many of which are difficult to
predict and generally beyond the control of WellPoint, that could cause actual
results to differ materially from those expressed in, or implied or projected
by, the forward-looking information and statements. These risks and
uncertainties include: those discussed and identified in public filings with
the U.S. Securities and Exchange Commission ("SEC") made by WellPoint;
increased government regulation of health benefits, managed care and pharmacy
benefit management operations; trends in health care costs and utilization
rates; our ability to secure sufficient premium rate increases; our ability to
contract with providers consistent with past practice; competitor pricing
below market trends of increasing costs; reduced enrollment, as well as a
negative change in our health care product mix; risks and uncertainties
regarding the Medicare Part D Prescription Drug benefits program, including
potential uncollectability of receivables resulting from processing and/or
verifying enrollment (including facilitated enrollment), inadequacy of
underwriting assumptions, inability to receive and process information,
uncollectability of premium from members, increased pharmaceutical costs, and
the underlying seasonality of the business; a downgrade in our financial
strength ratings; litigation and investigations targeted at health benefits
companies and our ability to resolve litigation and investigations within
estimates; our ability to achieve expected synergies and operating
efficiencies in the WellChoice, Inc. acquisition within the expected time
frames or at all, and to successfully integrate our operations; our ability to
meet expectations regarding repurchases of shares of our common stock;
funding risks with respect to revenue received from participation in Medicare
and Medicaid programs and the complex regulations imposed on Medicare fiscal
intermediaries; events that result in negative publicity for the health
benefits industry; failure to effectively maintain and modernize our
information systems and e-business organization and to maintain good
relationships with third party vendors for information system resources;
events that may negatively affect our license with the Blue Cross and Blue
Shield Association; possible impairment of the value of our intangible assets
if future results do not adequately support goodwill and other intangible
assets; intense competition to attract and retain employees; unauthorized
disclosure of member sensitive or confidential information; changes in the
economic and market conditions, as well as regulations, applicable to our
investment portfolios; possible restrictions in the payment of dividends by
our subsidiaries and increases in required minimum levels of capital and the
potential negative affect from our substantial amount of outstanding
indebtedness; general risks associated with mergers and acquisitions; various
laws and our governing documents may prevent or discourage takeovers and
business combinations; potential hedging activities in our common stock;
future bio-terrorist activity or other potential public health epidemics; and
general economic downturns. Readers are cautioned not to place undue reliance
on these forward-looking statements that speak only as of the date hereof.
Except to the extent otherwise required by federal securities law, WellPoint
does not undertake any obligation to republish revised forward-looking
statements to reflect events or circumstances after the date hereof or to
reflect the occurrence of unanticipated events. Readers are also urged to
carefully review and consider the various disclosures in WellPoint's SEC
reports.